Chris Sandberg
Family Medicine · St Joseph, MONPI 1639147408
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,025 and has fallen 84.4% since, to $160 in 2022.
Across 162 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$288
- Lilly USA, LLC$212
- Astellas Pharma US Inc$199
- Boehringer Ingelheim$196
- GSK$162
- AbbVie$124
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,43796%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 19 | $288 |
| Lilly USA, LLC | 16 | $212 |
| Astellas Pharma US Inc | 6 | $199 |
| Boehringer Ingelheim | 13 | $196 |
| GSK | 12 | $162 |
| AbbVie(2 entities) | 8 | $124 |
| Johnson & Johnson | 8 | $111 |
| Collegium Pharmaceutical, Inc. | 7 | $102 |
| Currax Pharmaceuticals LLC | 7 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $91 |
| Novartis | 6 | $91 |
| Merck | 6 | $86 |
| Pfizer | 6 | $85 |
| Otsuka America Pharmaceutical, Inc. | 5 | $79 |
| Boston Scientific | 2 | $78 |
| Sunovion Pharmaceuticals Inc. | 5 | $70 |
| Amarin Pharma, Inc. | 4 | $67 |
| Mylan Specialty L.p. | 4 | $50 |
| Nestle Healthcare Nutrition Inc. | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Novo Nordisk | 3 | $44 |
| Eisai Inc. | 3 | $40 |
| Abbott | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Genentech USA, Inc. | 2 | $25 |
| Bausch Health US, LLC | 1 | $20 |
| Amgen | 1 | $19 |
| Bayer | 1 | $16 |
| Phadia US Inc. | 1 | $15 |
| Circassia Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$2,537 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 12 | $70 |
Paid to pharmacies, not to this prescriber.
Other family medicine in St Joseph
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.